Abstract
The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Current Bioactive Compounds
Title: Aβ Monomers, Oligomers and Fibrils: Structural Features
Volume: 7 Issue: 3
Author(s): Cristina Airoldi, Erika Sironi, Barbara La Ferla, Francisco Cardona and Francesco Nicotra
Affiliation:
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Abstract: The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Export Options
About this article
Cite this article as:
Airoldi Cristina, Sironi Erika, La Ferla Barbara, Cardona Francisco and Nicotra Francesco, Aβ Monomers, Oligomers and Fibrils: Structural Features, Current Bioactive Compounds 2011; 7 (3) . https://dx.doi.org/10.2174/157340711796817896
DOI https://dx.doi.org/10.2174/157340711796817896 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting
Current Molecular Pharmacology Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews The Bioenergetics of Isolated Mitochondria from Different Animal Models for Diabetes
Current Diabetes Reviews Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
Current Pharmaceutical Design Phytoestrogens: Implications in Neurovascular Research
Current Neurovascular Research Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease
Current Medicinal Chemistry Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Neurological Aspects of Grief
CNS & Neurological Disorders - Drug Targets Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
Current Drug Targets Anticoagulant Therapy During Pregnancy for Maternal and Fetal Acquired and Inherited Thrombophilia
Current Medicinal Chemistry The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes
Current Protein & Peptide Science Echinochrome Pigment Improves Male Rats' Fertility
The Natural Products Journal Benefits of Olive Oil Phenolic Compounds in Disease Prevention
Endocrine, Metabolic & Immune Disorders - Drug Targets A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Insights into Oxidative Stress: The Isoprostanes
Current Medicinal Chemistry Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy